APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Coccidiosis Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Coccidiosis Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173979160328 December 2025195 pages

Choose your research edition.

Industry ResearchCoccidiosis Vaccines Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Coccidiosis Vaccines Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Coccidiosis Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coccidiosis Vaccines Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Coccidiosis Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Coccidiosis Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Coccidiosis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coccidiosis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coccidiosis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Coccidiosis Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coccidiosis Vaccines include Biopharm, Bioproperties, Boehringer Ingelheim, Ceva Santé Animale, HIPRA, Huvepharma, MSD Animal Health, Nisseiken and Vaxxinova, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Coccidiosis Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coccidiosis Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coccidiosis Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coccidiosis Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Coccidiosis Vaccines Segment by Company

Biopharm

Bioproperties

Boehringer Ingelheim

Ceva Santé Animale

HIPRA

Huvepharma

MSD Animal Health

Nisseiken

Vaxxinova

Foshan Standard Biotech

Guangdong Winsun Bio-pharmaceutical

Hlinte

Qilu Qingda Bio-Pharmaceutical

Skystar Bio-pharm

Coccidiosis Vaccines Segment by Type

Attenuated Vaccines

Non-attenuated Vaccines

Coccidiosis Vaccines Segment by Application

Poultry

Rabbit

Others

Coccidiosis Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coccidiosis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coccidiosis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coccidiosis Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coccidiosis Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Coccidiosis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Coccidiosis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Coccidiosis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Coccidiosis Vaccines Industry Trends Table 2. Coccidiosis Vaccines Industry Drivers Table 3. Coccidiosis Vaccines Industry Opportunities and Challenges Table 4. Coccidiosis Vaccines Industry Restraints Table 5. Global Coccidiosis Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Coccidiosis Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Coccidiosis Vaccines Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Coccidiosis Vaccines Sales Market Share by Manufacturers Table 9. Global Coccidiosis Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Coccidiosis Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Coccidiosis Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Coccidiosis Vaccines Manufacturers, Product Type & Application Table 13. Global Coccidiosis Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Coccidiosis Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Attenuated Vaccines Table 17. Major Manufacturers of Non-attenuated Vaccines Table 18. Global Coccidiosis Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units) Table 20. Global Coccidiosis Vaccines Sales by Type (2027-2032) & (K Units) Table 21. Global Coccidiosis Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Coccidiosis Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Coccidiosis Vaccines Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Coccidiosis Vaccines Revenue by Type (2021-2026) & (K Units) Table 25. Global Coccidiosis Vaccines Revenue by Type (2027-2032) & (K Units) Table 26. Global Coccidiosis Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Coccidiosis Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Poultry Table 29. Major Manufacturers of Rabbit Table 30. Major Manufacturers of Others Table 31. Global Coccidiosis Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Coccidiosis Vaccines Sales by Application (2021-2026) & (K Units) Table 33. Global Coccidiosis Vaccines Sales by Application (2027-2032) & (K Units) Table 34. Global Coccidiosis Vaccines Sales Market Share by Application (2021-2026) Table 35. Global Coccidiosis Vaccines Sales Market Share by Application (2027-2032) Table 36. Global Coccidiosis Vaccines Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Coccidiosis Vaccines Revenue by Application (2021-2026) & (K Units) Table 38. Global Coccidiosis Vaccines Revenue by Application (2027-2032) & (K Units) Table 39. Global Coccidiosis Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global Coccidiosis Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global Coccidiosis Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Coccidiosis Vaccines Sales by Region (2021-2026) & (K Units) Table 43. Global Coccidiosis Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Coccidiosis Vaccines Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Coccidiosis Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Coccidiosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units) Table 48. North America Coccidiosis Vaccines Sales by Country (2027-2032) & (K Units) Table 49. Europe Coccidiosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units) Table 51. Europe Coccidiosis Vaccines Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Coccidiosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Coccidiosis Vaccines Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Coccidiosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Coccidiosis Vaccines Sales by Country (2027-2032) & (K Units) Table 58. Global Coccidiosis Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Coccidiosis Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Coccidiosis Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Coccidiosis Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global Coccidiosis Vaccines Revenue Market Share by Region (2027-2032) Table 63. Biopharm Company Information Table 64. Biopharm Business Overview Table 65. Biopharm Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Biopharm Coccidiosis Vaccines Product Portfolio Table 67. Biopharm Recent Development Table 68. Bioproperties Company Information Table 69. Bioproperties Business Overview Table 70. Bioproperties Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bioproperties Coccidiosis Vaccines Product Portfolio Table 72. Bioproperties Recent Development Table 73. Boehringer Ingelheim Company Information Table 74. Boehringer Ingelheim Business Overview Table 75. Boehringer Ingelheim Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Coccidiosis Vaccines Product Portfolio Table 77. Boehringer Ingelheim Recent Development Table 78. Ceva Santé Animale Company Information Table 79. Ceva Santé Animale Business Overview Table 80. Ceva Santé Animale Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Ceva Santé Animale Coccidiosis Vaccines Product Portfolio Table 82. Ceva Santé Animale Recent Development Table 83. HIPRA Company Information Table 84. HIPRA Business Overview Table 85. HIPRA Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. HIPRA Coccidiosis Vaccines Product Portfolio Table 87. HIPRA Recent Development Table 88. Huvepharma Company Information Table 89. Huvepharma Business Overview Table 90. Huvepharma Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Huvepharma Coccidiosis Vaccines Product Portfolio Table 92. Huvepharma Recent Development Table 93. MSD Animal Health Company Information Table 94. MSD Animal Health Business Overview Table 95. MSD Animal Health Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. MSD Animal Health Coccidiosis Vaccines Product Portfolio Table 97. MSD Animal Health Recent Development Table 98. Nisseiken Company Information Table 99. Nisseiken Business Overview Table 100. Nisseiken Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Nisseiken Coccidiosis Vaccines Product Portfolio Table 102. Nisseiken Recent Development Table 103. Vaxxinova Company Information Table 104. Vaxxinova Business Overview Table 105. Vaxxinova Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Vaxxinova Coccidiosis Vaccines Product Portfolio Table 107. Vaxxinova Recent Development Table 108. Foshan Standard Biotech Company Information Table 109. Foshan Standard Biotech Business Overview Table 110. Foshan Standard Biotech Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Foshan Standard Biotech Coccidiosis Vaccines Product Portfolio Table 112. Foshan Standard Biotech Recent Development Table 113. Guangdong Winsun Bio-pharmaceutical Company Information Table 114. Guangdong Winsun Bio-pharmaceutical Business Overview Table 115. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Product Portfolio Table 117. Guangdong Winsun Bio-pharmaceutical Recent Development Table 118. Hlinte Company Information Table 119. Hlinte Business Overview Table 120. Hlinte Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Hlinte Coccidiosis Vaccines Product Portfolio Table 122. Hlinte Recent Development Table 123. Qilu Qingda Bio-Pharmaceutical Company Information Table 124. Qilu Qingda Bio-Pharmaceutical Business Overview Table 125. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Product Portfolio Table 127. Qilu Qingda Bio-Pharmaceutical Recent Development Table 128. Skystar Bio-pharm Company Information Table 129. Skystar Bio-pharm Business Overview Table 130. Skystar Bio-pharm Coccidiosis Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Skystar Bio-pharm Coccidiosis Vaccines Product Portfolio Table 132. Skystar Bio-pharm Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Coccidiosis Vaccines Distributors List Table 136. Coccidiosis Vaccines Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Coccidiosis Vaccines Product Image Figure 2. Global Coccidiosis Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coccidiosis Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Coccidiosis Vaccines Sales (2021-2032) & (K Units) Figure 5. Global Coccidiosis Vaccines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Coccidiosis Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Attenuated Vaccines Image Figure 9. Non-attenuated Vaccines Image Figure 10. Global Coccidiosis Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Coccidiosis Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Coccidiosis Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Coccidiosis Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Coccidiosis Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Coccidiosis Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Poultry Image Figure 17. Rabbit Image Figure 18. Others Image Figure 19. Global Coccidiosis Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Coccidiosis Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Coccidiosis Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global Coccidiosis Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Coccidiosis Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Coccidiosis Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Coccidiosis Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Coccidiosis Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Coccidiosis Vaccines Sales Market Share by Country (2021-2032) Figure 39. China Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Coccidiosis Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Coccidiosis Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Coccidiosis Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Coccidiosis Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Coccidiosis Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America Coccidiosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Coccidiosis Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe Coccidiosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Coccidiosis Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Coccidiosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Coccidiosis Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Coccidiosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Coccidiosis Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Coccidiosis Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Attenuated Vaccines
  • Non-attenuated Vaccines
Applications
  • Poultry
  • Rabbit
  • Others
Companies covered
  • Biopharm
  • Bioproperties
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • HIPRA
  • Huvepharma
  • MSD Animal Health
  • Nisseiken
  • Vaxxinova
  • Foshan Standard Biotech
  • Guangdong Winsun Bio-pharmaceutical
  • Hlinte
  • Qilu Qingda Bio-Pharmaceutical
  • Skystar Bio-pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Coccidiosis Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Coccidiosis Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Coccidiosis Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Coccidiosis Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Coccidiosis Vaccines Market Dynamics
  1. 2.1 Coccidiosis Vaccines Industry Trends
  2. 2.2 Coccidiosis Vaccines Industry Drivers
  3. 2.3 Coccidiosis Vaccines Industry Opportunities and Challenges
  4. 2.4 Coccidiosis Vaccines Industry Restraints
3 Coccidiosis Vaccines Market by Manufacturers
  1. 3.1 Global Coccidiosis Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Coccidiosis Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Coccidiosis Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Coccidiosis Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Coccidiosis Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Coccidiosis Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Coccidiosis Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Coccidiosis Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Coccidiosis Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Coccidiosis Vaccines Tier 1, Tier 2, and Tier 3
4 Coccidiosis Vaccines Market by Type
  1. 4.1 Coccidiosis Vaccines Type Introduction
  2. 4.1.1 Attenuated Vaccines
  3. 4.1.2 Non-attenuated Vaccines
  4. 4.2 Global Coccidiosis Vaccines Sales by Type
  5. 4.2.1 Global Coccidiosis Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Coccidiosis Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Coccidiosis Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Coccidiosis Vaccines Revenue by Type
  9. 4.3.1 Global Coccidiosis Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Coccidiosis Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Coccidiosis Vaccines Revenue Market Share by Type (2021-2032)
5 Coccidiosis Vaccines Market by Application
  1. 5.1 Coccidiosis Vaccines Application Introduction
  2. 5.1.1 Poultry
  3. 5.1.2 Rabbit
  4. 5.1.3 Others
  5. 5.2 Global Coccidiosis Vaccines Sales by Application
  6. 5.2.1 Global Coccidiosis Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Coccidiosis Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global Coccidiosis Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global Coccidiosis Vaccines Revenue by Application
  10. 5.3.1 Global Coccidiosis Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Coccidiosis Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global Coccidiosis Vaccines Revenue Market Share by Application (2021-2032)
6 Global Coccidiosis Vaccines Sales by Region
  1. 6.1 Global Coccidiosis Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coccidiosis Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Coccidiosis Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Coccidiosis Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Coccidiosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Coccidiosis Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Coccidiosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Coccidiosis Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Coccidiosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Coccidiosis Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Coccidiosis Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Coccidiosis Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Coccidiosis Vaccines Revenue by Region
  1. 7.1 Global Coccidiosis Vaccines Revenue by Region
  2. 7.1.1 Global Coccidiosis Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Coccidiosis Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Coccidiosis Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Coccidiosis Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Coccidiosis Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Coccidiosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Coccidiosis Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Coccidiosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Coccidiosis Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Coccidiosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Coccidiosis Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Coccidiosis Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Biopharm
  2. 8.1.1 Biopharm Company Information
  3. 8.1.2 Biopharm Business Overview
  4. 8.1.3 Biopharm Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biopharm Coccidiosis Vaccines Product Portfolio
  6. 8.1.5 Biopharm Recent Developments
  7. 8.2 Bioproperties
  8. 8.2.1 Bioproperties Company Information
  9. 8.2.2 Bioproperties Business Overview
  10. 8.2.3 Bioproperties Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bioproperties Coccidiosis Vaccines Product Portfolio
  12. 8.2.5 Bioproperties Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Coccidiosis Vaccines Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Ceva Santé Animale
  20. 8.4.1 Ceva Santé Animale Company Information
  21. 8.4.2 Ceva Santé Animale Business Overview
  22. 8.4.3 Ceva Santé Animale Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ceva Santé Animale Coccidiosis Vaccines Product Portfolio
  24. 8.4.5 Ceva Santé Animale Recent Developments
  25. 8.5 HIPRA
  26. 8.5.1 HIPRA Company Information
  27. 8.5.2 HIPRA Business Overview
  28. 8.5.3 HIPRA Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HIPRA Coccidiosis Vaccines Product Portfolio
  30. 8.5.5 HIPRA Recent Developments
  31. 8.6 Huvepharma
  32. 8.6.1 Huvepharma Company Information
  33. 8.6.2 Huvepharma Business Overview
  34. 8.6.3 Huvepharma Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Huvepharma Coccidiosis Vaccines Product Portfolio
  36. 8.6.5 Huvepharma Recent Developments
  37. 8.7 MSD Animal Health
  38. 8.7.1 MSD Animal Health Company Information
  39. 8.7.2 MSD Animal Health Business Overview
  40. 8.7.3 MSD Animal Health Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MSD Animal Health Coccidiosis Vaccines Product Portfolio
  42. 8.7.5 MSD Animal Health Recent Developments
  43. 8.8 Nisseiken
  44. 8.8.1 Nisseiken Company Information
  45. 8.8.2 Nisseiken Business Overview
  46. 8.8.3 Nisseiken Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nisseiken Coccidiosis Vaccines Product Portfolio
  48. 8.8.5 Nisseiken Recent Developments
  49. 8.9 Vaxxinova
  50. 8.9.1 Vaxxinova Company Information
  51. 8.9.2 Vaxxinova Business Overview
  52. 8.9.3 Vaxxinova Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vaxxinova Coccidiosis Vaccines Product Portfolio
  54. 8.9.5 Vaxxinova Recent Developments
  55. 8.10 Foshan Standard Biotech
  56. 8.10.1 Foshan Standard Biotech Company Information
  57. 8.10.2 Foshan Standard Biotech Business Overview
  58. 8.10.3 Foshan Standard Biotech Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Foshan Standard Biotech Coccidiosis Vaccines Product Portfolio
  60. 8.10.5 Foshan Standard Biotech Recent Developments
  61. 8.11 Guangdong Winsun Bio-pharmaceutical
  62. 8.11.1 Guangdong Winsun Bio-pharmaceutical Company Information
  63. 8.11.2 Guangdong Winsun Bio-pharmaceutical Business Overview
  64. 8.11.3 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Product Portfolio
  66. 8.11.5 Guangdong Winsun Bio-pharmaceutical Recent Developments
  67. 8.12 Hlinte
  68. 8.12.1 Hlinte Company Information
  69. 8.12.2 Hlinte Business Overview
  70. 8.12.3 Hlinte Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hlinte Coccidiosis Vaccines Product Portfolio
  72. 8.12.5 Hlinte Recent Developments
  73. 8.13 Qilu Qingda Bio-Pharmaceutical
  74. 8.13.1 Qilu Qingda Bio-Pharmaceutical Company Information
  75. 8.13.2 Qilu Qingda Bio-Pharmaceutical Business Overview
  76. 8.13.3 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Product Portfolio
  78. 8.13.5 Qilu Qingda Bio-Pharmaceutical Recent Developments
  79. 8.14 Skystar Bio-pharm
  80. 8.14.1 Skystar Bio-pharm Company Information
  81. 8.14.2 Skystar Bio-pharm Business Overview
  82. 8.14.3 Skystar Bio-pharm Coccidiosis Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Skystar Bio-pharm Coccidiosis Vaccines Product Portfolio
  84. 8.14.5 Skystar Bio-pharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Coccidiosis Vaccines Value Chain Analysis
  2. 9.1.1 Coccidiosis Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Coccidiosis Vaccines Production Mode & Process
  6. 9.2 Coccidiosis Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Coccidiosis Vaccines Distributors
  9. 9.2.3 Coccidiosis Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst